Skip to content

A clinical trial to study the effect of ayurvedic drug formualtion Amrutadi Yog in patients with high blood presssure.

Randomized Controlled Clinical Trial to Evaluate the Efficacy of Amrutadi Yog in Essential Hypertension

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/05/019423
Enrollment
220
Registered
2019-05-29
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Amrutadi Yog: Amrutadi Yog 1 gram twice in a day after meal Total Duration of Therapy- 8 weeks Control Intervention1: Tb Telmisartan: Tb. Telmisartan 20 mili gram Once in a Day T

Sponsors

Nil
Lead Sponsor
private college
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Newly diagnosed patients of stage 1 essential hypertension with blood pressure systolic blood pressure is equal to and more than 140 mmHg and less than 160 mmHg and diastolic blood pressure is equal to and more than 90 mmHg and less than 100 mmHg

Exclusion criteria

Exclusion criteria: 1.Patients receiving anti-hypertensive drug. 2.Complicated hypertensive cases. Known case of Nephropathy, Left Ventricular Hypertrophy, heart block, Congestive Cardiac Failure, Coronary Artery Disease and retinopathy. Patients suffering from Diabetes Mellitus and severe other illness like hepatic or renal failure. 3.Secondary, Accelerated and Malignant Hypertension 4.Patients taking steroids, oral contraceptive pills, estrogen replacement therapy or NSAIDS group of drug 5.Pregnant women or planning pregnancy within six months.

Design outcomes

Primary

MeasureTime frame
reduction in blood pressure Timepoint: 8 weeks

Secondary

MeasureTime frame
sign and symptoms of hypertension rliefTimepoint: 8 weeks

Countries

India

Contacts

Public ContactVARSHA SADASHIV KHOT

Maharashtra University of Health Sciences Nashik

drvarshaskhot@gmail.com09423565886

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026